8-K
Current Report
Jasper Therapeutics, Inc. Filed Acc 0001213900-22-012935
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea156967-8k_jasperther.htm…